Key result
Carnosic acid protects against doxorubicin-induced cardiotoxicity by enhancing the Nrf2/HO-1 pathway in preclinical models.
Why the study?
Does carnosic acid prevent doxorubicin-associated myocardiopathy?
Does carnosic acid prevent doxorubicin-associated myocardiopathy?
Carnosic acid shows potential as a therapeutic strategy to prevent doxorubicin-induced cardiotoxicity by enhancing the Nrf2/HO-1 pathway.
Answers are grounded in this paper and cite their sources.
Cautious preclinical signal for doxorubicin cardiotoxicity prevention; leaves open translation to human trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2023) studied Doxorubicin-induced cardiotoxicity. Carnosic acid was evaluated. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway in preclinical models.
Synapse has enriched 10 related papers. Consider them for comparative context: